Skip to content

Clinical trials

Phase 2 Insulin Resistance trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 2 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20091
20121
20151
20171
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Becton, Dickinson and Company1
Boehringer Ingelheim1
Charite University, Berlin, Germany1
Novartis1
Tanabe Pharma Corporation1
University Hospital Schleswig-Holstein1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance9
Obesity3
Diabetes Mellitus2
Diabetes Mellitus, Type 12
Diabetes Mellitus, Type 22
Glucose Intolerance2
Hyperandrogenism1
Hypertension1
Metabolic Syndrome1
Overweight1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.